Lahar Mehta

Lahar Mehta is the Chief Medical Officer at Nura Bio since January 2025, previously holding the position of Senior Vice President and Vice President/Head of Global Clinical Development at Amylyx Pharmaceuticals from October 2021 to December 2024. Lahar has extensive experience in clinical development and neurology, serving as Vice President of Clinical Development at Annexon Biosciences and Alder Biopharmaceuticals/Lundbeck Seattle Biopharmaceuticals. Additional roles include Senior Medical Director at Genentech and Medical Director at Amgen and Biogen, with a focus on neurology and clinical research. Lahar began a career in neurology as a clinical neurologist and consultant at Evergreen Neuroscience Institute. Educational qualifications include a Doctor of Medicine from Meharry Medical College, a neurology residency at the University of Utah, and a fellowship in Experimental Therapeutics and Neuroimmunology from the University of Rochester.